AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8061530 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing against Flaviviridae viruses (yellow fever, dengue type 1 and 2, West Nile, Wesselsbron) using haemagglutination inhibition test
Number of subjects: 2507
Study 8061530 — intervention group
Group type: COMPARATOR
Intervention: Previous serosurvey from 1971
Number of subjects: 2507
Study 2898045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal glucagon (7.5 mg)
Number of subjects: 12
Study 2898045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal glucagon
Number of subjects: 12
Study 30950580 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg Lutein and Zeaxanthin (L+Z)
Number of subjects: 0
Study 30950580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27925283 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (4 mg oral dose)
Number of subjects: 24
Study 27925283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 26156311 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbronchial needle aspiration (TBNA) and transbronchial catheter aspiration (TBCA) combined
Number of subjects: 46
Study 26156311 — intervention group
Group type: COMPARATOR
Intervention: Transbronchial forceps biopsy (TBB)
Number of subjects: 46
Study 26156311 — intervention group
Group type: EXPERIMENTAL
Intervention: All modalities (TBB, TBNA, TBCA)
Number of subjects: 46
Study 23549100 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab and dexamethasone combination therapy (Group 1)
Number of subjects: 37
Study 23549100 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal ranibizumab monotherapy (Group 2)
Number of subjects: 37
Study 21421574 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy alone (Group A, 40 patients)
Number of subjects: 120
Study 21421574 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroanatomic integration (Cartomerge®, Group B, 40 patients)
Number of subjects: 120
Study 21421574 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroanatomic integration plus catheters visualization (Carto® 3 System, Group C, 40 patients)
Number of subjects: 120
Study 19554090 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive statin therapy aiming for LDL-cholesterol levels below 70 mg/dL
Number of subjects: 0
Study 19554090 — intervention group
Group type: COMPARATOR
Intervention: Standard statin therapy aiming for LDL-cholesterol levels < or =100 mg/dL
Number of subjects: 0
Study 18093504 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcaneous ultrasound bone mineral density (BMD) measurement using Achilles Express(R)
Number of subjects: 146
Study 18093504 — intervention group
Group type: COMPARATOR
Intervention: Dual energy x-ray absorptiometry (DXA)
Number of subjects: 146
Study 15199111 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1200 mg/day)
Number of subjects: 930
Study 15199111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 930
Study 11748341 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate therapy (discontinued after 52 weeks)
Number of subjects: 114
Study 11748341 — intervention group
Group type: COMPARATOR
Intervention: Calcium alone (500 mg/d)
Number of subjects: 114
Study 9709143 — intervention group
Group type: EXPERIMENTAL
Intervention: Size 5 laryngeal mask airway
Number of subjects: 30
Study 9709143 — intervention group
Group type: EXPERIMENTAL
Intervention: Size 4 laryngeal mask airway
Number of subjects: 30
Study 9709143 — intervention group
Group type: COMPARATOR
Intervention: Size 3 laryngeal mask airway
Number of subjects: 30
Study 9709143 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal leak pressure for size 4 and size 5
Number of subjects: 30
Study 9709143 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiberoptic view for size 4 and size 5
Number of subjects: 30
Study 9709143 — intervention group
Group type: COMPARATOR
Intervention: Height as a predictive variable
Number of subjects: 30
Study 7751528 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide nasal spray
Number of subjects: 233
Study 7751528 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (vehicle)
Number of subjects: 233
Study 2274802 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal diabetes education programme
Number of subjects: 309
Study 2274802 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial diabetes control and psychosocial factors
Number of subjects: 309
Study 106963 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nonabsorbable antibiotics plus isolation
Number of subjects: 24
Study 106963 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics alone
Number of subjects: 24
Study 106963 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 31761149 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention using wearable devices (Fitbit activity tracker, Beddit sleep tracker, Moves app, Careportal home monitoring system) over 210 days
Number of subjects: 70
Study 31761149 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 70
Study 31151076 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical human platelet lysate
Number of subjects: 30
Study 31151076 — intervention group
Group type: COMPARATOR
Intervention: Topical Clobetasol Propionate
Number of subjects: 30
Study 28093041 — intervention group
Group type: EXPERIMENTAL
Intervention: Global (single medium)
Number of subjects: 31
Study 28093041 — intervention group
Group type: COMPARATOR
Intervention: ISM1/BlastAssist (sequential media)
Number of subjects: 31
Study 25557208 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy
Number of subjects: 304
Study 25557208 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy
Number of subjects: 304
Study 25557208 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy (after multiple imputation)
Number of subjects: 304
Study 25557208 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (after multiple imputation)
Number of subjects: 304
Study 23538208 — intervention group
Group type: EXPERIMENTAL
Intervention: RNS(®) System, NeuroPace, Inc. (investigational responsive neurostimulation device)
Number of subjects: 191
Study 23538208 — intervention group
Group type: EXPERIMENTAL
Intervention: Depth electrodes
Number of subjects: 191
Study 23538208 — intervention group
Group type: EXPERIMENTAL
Intervention: Subdural electrodes
Number of subjects: 191
Study 22018220 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost in saline solution for three weeks
Number of subjects: 52
Study 22018220 — intervention group
Group type: COMPARATOR
Intervention: Saline solution only (control group)
Number of subjects: 52
Study 19583077 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual injection of 0.3 ml/kg lidocaine 0.5%
Number of subjects: 14
Study 19583077 — intervention group
Group type: COMPARATOR
Intervention: Automatic pump injection of 0.3 ml/kg lidocaine 0.5%
Number of subjects: 14
Study 16754920 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mL of coffee (200 mg of caffeine)
Number of subjects: 12
Study 16754920 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute nap
Number of subjects: 12
Study 16754920 — intervention group
Group type: COMPARATOR
Intervention: Placebo (decaffeinated coffee containing 15 mg of caffeine)
Number of subjects: 12
Study 14707022 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological pacemakers
Number of subjects: 1474
Study 14707022 — intervention group
Group type: COMPARATOR
Intervention: Ventricular pacemakers
Number of subjects: 1474
Study 11722052 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm cardiopulmonary bypass (CPB) at 35.5 to 36.5 degrees C
Number of subjects: 300
Study 11722052 — intervention group
Group type: COMPARATOR
Intervention: Cold cardiopulmonary bypass (CPB) at 28 degrees C to 30 degrees C
Number of subjects: 300
Study 9142583 — intervention group
Group type: COMPARATOR
Intervention: Constant light sedation (CLS) over 50 h aiming for a Ramsay score of 2‐3
Number of subjects: 30
Study 9142583 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional night sedation (ANS) with propofol between 2200 h and 0600 h, aiming for a sedation score of 4‐5
Number of subjects: 30
Study 9142583 — intervention group
Group type: COMPARATOR
Intervention: Constant light sedation (CLS)
Number of subjects: 30
Study 9142583 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional night sedation (ANS)
Number of subjects: 30
Study 8154631 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 39
Study 8154631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 2964080 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate meal
Number of subjects: 12
Study 2964080 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat meal
Number of subjects: 12
Study 2964080 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein meal
Number of subjects: 12
Study 2964080 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (400 ml at room temperature)
Number of subjects: 12
Study 2964080 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (400 ml at 4 degrees C)
Number of subjects: 12
Study 29360932 — intervention group
Group type: EXPERIMENTAL
Intervention: palbociclib plus letrozole
Number of subjects: 666
Study 29360932 — intervention group
Group type: COMPARATOR
Intervention: letrozole alone
Number of subjects: 666
Study 28656452 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication Adherence Rating Scale (MARS)
Number of subjects: 218
Study 28656452 — intervention group
Group type: EXPERIMENTAL
Intervention: First-generation antipsychotic use
Number of subjects: 218
Study 28656452 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher illness severity (MCSI score)
Number of subjects: 218
Study 28656452 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower 'acceptance of illness' (MCAS score)
Number of subjects: 218
Study 26206451 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy
Number of subjects: 208
Study 26206451 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy with suspension of the uterosacral ligaments
Number of subjects: 208
Study 26206451 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall anatomical recurrences, functional outcome, quality of life, complications, hospital stay, measures on postoperative recovery, and sexual functioning
Number of subjects: 208
Study 23782410 — intervention group
Group type: EXPERIMENTAL
Intervention: Vapotherm 2000i at 7 L/min
Number of subjects: 9
Study 23782410 — intervention group
Group type: COMPARATOR
Intervention: Fisher & Paykel HHHFNC at 7 L/min
Number of subjects: 9
Study 23782410 — intervention group
Group type: EXPERIMENTAL
Intervention: Vapotherm 2000i at 8 L/min
Number of subjects: 9
Study 23782410 — intervention group
Group type: COMPARATOR
Intervention: Fisher & Paykel HHHFNC at 8 L/min
Number of subjects: 9
Study 20101009 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive medical intervention (IMI)
Number of subjects: 597
Study 20101009 — intervention group
Group type: COMPARATOR
Intervention: Usual care condition (UCC)
Number of subjects: 597
Study 17935639 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 59
Study 17935639 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 59
Study 16859516 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant Behavioural Treatment (OBT)
Number of subjects: 125
Study 16859516 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Treatment (CBT)
Number of subjects: 125
Study 16859516 — intervention group
Group type: COMPARATOR
Intervention: Attention-Placebo (AP)
Number of subjects: 125
Study 14634878 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic aspiration and fibrinolysis with 3 mg rTPA
Number of subjects: 121
Study 14634878 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment according to best medical treatment
Number of subjects: 121
Study 11013189 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone IOL
Number of subjects: 200
Study 11013189 — intervention group
Group type: COMPARATOR
Intervention: Acrylic IOL
Number of subjects: 200
Study 8779363 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral benzocaine 20 mg
Number of subjects: 23
Study 8779363 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine 100 mg sprayed onto vocal cords
Number of subjects: 23
Study 8779363 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised lignocaine 4 ml (4%)
Number of subjects: 23
Study 1417481 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra‐arterial doxorubicin hydrochloride, limb salvage surgery, and radiation (group A)
Number of subjects: 38
Study 1417481 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin, isolated limb perfusion, limb salvage surgery, and radiation (group B)
Number of subjects: 38
Study 6437150 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal Intervention 1 (MI1)
Number of subjects: 0
Study 6437150 — intervention group
Group type: COMPARATOR
Intervention: Shortened, less intensive 6-week behavioral weight loss program (three variations)
Number of subjects: 0
Study 6437150 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal Intervention 2 (MI2)
Number of subjects: 0
Study 6437150 — intervention group
Group type: COMPARATOR
Intervention: Full-length behavioral program (two variations)
Number of subjects: 0
Study 30536746 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipragliflozin
Number of subjects: 49
Study 30536746 — intervention group
Group type: COMPARATOR
Intervention: Control (no additional treatment)
Number of subjects: 49
Study 30007574 — intervention group
Group type: EXPERIMENTAL
Intervention: GSM 900MHz RF-EMFs emitted from a mobile phone stimulator for 4 hours, SAR 2.287W/kg
Number of subjects: 20
Study 30007574 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-exposed to RF-EMFs)
Number of subjects: 20
Study 30007574 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of nickel levels between exposed and non-exposed groups
Number of subjects: 20
Study 26787597 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler-guided haemorrhoidal artery ligation with mucopexy (Group A)
Number of subjects: 40
Study 26787597 — intervention group
Group type: COMPARATOR
Intervention: Suture mucopexy alone (Group B)
Number of subjects: 40
Study 26787597 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 40
Study 25517773 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture adhesive (DA) used during the first 15 days
Number of subjects: 50
Study 25517773 — intervention group
Group type: COMPARATOR
Intervention: No denture adhesive (DA) used during the first 15 days
Number of subjects: 50
Study 22042588 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent soft short hood
Number of subjects: 112
Study 19720939 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 270
Study 19720939 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 270
Study 17805074 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 127
Study 17805074 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous stress fractures
Number of subjects: 127
Study 17805074 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower whole-body bone mineral content
Number of subjects: 127
Study 17805074 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger chronologic age
Number of subjects: 127
Study 17805074 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dietary calcium intake
Number of subjects: 127
Study 17805074 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age at menarche
Number of subjects: 127
Study 17805074 — intervention group
Group type: EXPERIMENTAL
Intervention: History of irregular menstrual periods
Number of subjects: 127
Study 15205062 — intervention group
Group type: EXPERIMENTAL
Intervention: Menopausal Sexual Interest Questionnaire (MSIQ)
Number of subjects: 0
Study 11239030 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop diuretics (torasemide or frusemide), 3 mg/kg body weight i.v. every 6 h
Number of subjects: 7
Study 11239030 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy adults)
Number of subjects: 7
Study 9519355 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal androgen blockade (goserelin acetate 3.6 mg s.c. once every 4 weeks + flutamide 250 mg 3 x daily)
Number of subjects: 0
Study 9519355 — intervention group
Group type: COMPARATOR
Intervention: Bilateral orchiectomy
Number of subjects: 0
Study 7988809 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact with a medical specialty prior to entering medical school
Number of subjects: 161
Study 7988809 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal of entering family practice
Number of subjects: 161
Study 3143576 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (1 g for seven days)
Number of subjects: 205
Study 3143576 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline (100 mg)
Number of subjects: 205
Study 3143576 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline (200 mg)
Number of subjects: 205
Study 31526792 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertile women
Number of subjects: 75784
Study 31526792 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertile women at low risk of mortality
Number of subjects: 75784
Study 31526792 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertile women at low risk of cancer mortality
Number of subjects: 75784
Study 31526792 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertile women at low risk of breast cancer death
Number of subjects: 75784
Study 30526560 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling and a paper based calendar
Number of subjects: 3360
Study 30526560 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling and a cell phone based SMS alert system
Number of subjects: 3360
Study 30526560 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling and smart-phone application
Number of subjects: 3360
Study 30526560 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 3360
Study 27851679 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up (TFU) 4 and 14 days after discharge in addition to conventional treatment
Number of subjects: 117
Study 27851679 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 117
Study 24862944 — intervention group
Group type: EXPERIMENTAL
Intervention: SPARKLE classification system
Number of subjects: 275
Study 24862944 — intervention group
Group type: COMPARATOR
Intervention: CCS classification system
Number of subjects: 275
Study 24862944 — intervention group
Group type: COMPARATOR
Intervention: TOAST classification system
Number of subjects: 275
Study 22428572 — intervention group
Group type: EXPERIMENTAL
Intervention: All-purpose nipple ointment (APNO)
Number of subjects: 151
Study 22428572 — intervention group
Group type: COMPARATOR
Intervention: Lanolin (control)
Number of subjects: 151
Study 20382075 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated regimen of six fractions of radiotherapy per week (n=458)
Number of subjects: 908
Study 20382075 — intervention group
Group type: COMPARATOR
Intervention: Conventional regimen of five fractions of radiotherapy per week (n=450)
Number of subjects: 908
Study 19120717 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) 20 mg/d, up-titrated to 40 mg/d, then OM/HCTZ 40/12.5 mg/d, and OM/HCTZ 40/25 mg/d
Number of subjects: 276
Study 19120717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study 19120717 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM)
Number of subjects: 276
Study 16373084 — intervention group
Group type: EXPERIMENTAL
Intervention: TACO (600-1200 mg DSM)
Number of subjects: 74
Study 16373084 — intervention group
Group type: COMPARATOR
Intervention: TACP
Number of subjects: 74
Study 14599408 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir (SQV)
Number of subjects: 137
Study 14599408 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir (IDV)
Number of subjects: 137
Study 14599408 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir (RTV)
Number of subjects: 137
Study 14599408 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 137
Study 10936148 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine inhalation (5 mg/kg)
Number of subjects: 15
Study 10936148 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol inhalation (1.5 mg)
Number of subjects: 15
Study 10936148 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined lidocaine and salbutamol inhalation
Number of subjects: 15
Study 10936148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8733444 — intervention group
Group type: EXPERIMENTAL
Intervention: True ultrasound (0.5 w/cm2, 3 MHz, pulsed 1:4) for eight minutes
Number of subjects: 19
Study 8733444 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound (only the timer activated)
Number of subjects: 19
Study 1431007 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0
Study 1431007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3904806 — intervention group
Group type: EXPERIMENTAL
Intervention: Short contact therapy with 1%, 2%, and 3% dithranol (30 min)
Number of subjects: 30
Study 3904806 — intervention group
Group type: COMPARATOR
Intervention: Overnight therapy with 1%, 2%, and 3% dithranol
Number of subjects: 30
Study 30668322 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisia afra
Number of subjects: 957
Study 30668322 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisia annua
Number of subjects: 957
Study 30668322 — intervention group
Group type: COMPARATOR
Intervention: artesunate-amodiaquine (ASAQ)
Number of subjects: 957
Study 29407494 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear Aligners (CLA)
Number of subjects: 71
Study 29407494 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Ligated Brackets (SLB)
Number of subjects: 71
Study 29407494 — intervention group
Group type: COMPARATOR
Intervention: Conventional Elastomeric Ligated Brackets (ELB)
Number of subjects: 71